Latest Vivesto News & Updates

See the latest news and media coverage for Vivesto. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Vivesto

Swedish oncology drug development company

vivesto.com
Headquarters
Stockholm, Sweden
Founded year
1999
Company type
Public company
Number of employees
2–30

Last updated

Latest news about Vivesto

In short: Vivesto conducted a 1:100 reverse share split, advanced its oncology pipeline through clinical trials, and secured new funding via a rights issue.

Company announcements

  • Vivesto

    Vivesto holds Annual General Meeting

    Resolutions include adopting financial statements, no dividend, board re-elections, reverse share split 1:100, share capital reduction, and board issue authorization.

  • Vivesto

    Vivesto proposes reverse share split and capital reduction

    The Board proposes consolidating 100 shares into 1 and reducing share capital from SEK 110,713,691 to SEK 11,071,369 for AGM on May 7, 2026.

  • Vivesto

    Vivesto announces first dogs dosed in Cantrixil PK/toxicology study

    The study supports development for human AML and dog cancer pilot. Early observations show good tolerability. Results expected summer 2026.

  • Vivesto

    Vivesto announces new total shares and votes

    Rights issue increases shares by 538,043,455; set-off issue by 31,050,000. Total now 1,107,136,910.

Unlock all announcements with a

Media coverage

Unlock all articles with a

Never miss news about Vivesto

Track Vivesto and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Vivesto competitors & trending companies

Browse news for competitors to Vivesto and other trending companies.